# US 2020/0392089 A1 · Novel Amide Compounds and Use Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0392089 A1
- Document ID: US20200392089A1
- Status: Published application
- Kind: A1
- Application number: 16/877,593
- Filed: 2020-05-19
- Published: 2020-12-17
- Earliest claimed: 2019-06-12
- Assignees: NeoPharm, Inc.
- Applicants: NeoPharm Co., Ltd.
- Inventors: Kyung Sook Yoo; Bu-Mahn Park; Min Hee Kim; Yu Ra Jung; Hye Seong Shin
- Web page: https://patentgrep.com/patent/US20200392089A1

## CPC

- C07D 233/64: with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C07C 235/80: having carbon atoms of carboxamide groups and keto groups bound to the same carbon atom, e.g. acetoacetamides
- C07C 279/14: being further substituted by carboxyl groups
- C07D 209/20: substituted additionally by nitrogen atoms, e.g. tryptophane
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Provided are a novel amide compound and a use thereof. According to the present invention, there may be provided a use of a novel amide compound which is harmless to the human body with excellent skin stability and decreases activity of peroxisome proliferator activated receptor gamma (PPAR-γ) to fundamentally inhibit sebum overproduction, thereby providing the skin with an effective effect, and a cosmetic composition including the same.

## Claims

### Claim 1

An amide compound represented by the following Chemical Formula 1, a pharmaceutically acceptable salt thereof, or a solvate thereof:
wherein
R1 and R2 are independently of each other (C1-C30) alkyl;
one selected from R3 and R4 is (C1-C30) alkyl, and the other one is hydrogen or (C1-C30) alkyl;
R5 is hydrogen or (C1-C30)alkyl; and
the alkyl of R3 and R4 may be further substituted by one or more substituents selected from hydroxy; (C1-C30) alkoxy; (C1-C30) alkylthio; and amino, guanidino, —(C═O)NH2, —(C═O)OR, (C3-C30) heteroaryl, and salts thereof, in which R is hydrogen or (C1-C30) alkyl, and the heteroaryl contains N.

### Claim 2 (depends on 1)

The amide compound, the pharmaceutically acceptable salt thereof, or the solvate thereof of claim 1, wherein
R3 is (C1-C7) alkyl; and
R4 is hydrogen.

### Claim 3 (depends on 1)

The amide compound, the pharmaceutically acceptable salt thereof, or the solvate thereof of claim 1, wherein
R3 is (C1-C7) alkyl and the alkyl is further substituted by one or more substituents selected from hydroxy, (C1-C7) alkoxy, and (C1-C7) alkylthio; and
R4 is hydrogen.

### Claim 4 (depends on 1)

The amide compound, the pharmaceutically acceptable salt thereof, or the solvate thereof of claim 1, wherein
R3 is (C1-C7) alkyl and the alkyl is further substituted by one or more substituents selected from amino (—NH2), guanidino, —(C═O)NH2, (C3-C10) heteroaryl, and salts thereof; and
R4 is hydrogen.

### Claim 5 (depends on 1)

The amide compound, the pharmaceutically acceptable salt thereof, or the solvate thereof of claim 1, wherein
R3 is (C2-C7) alkyl and the alkyl is further substituted by —(C═O)OR, in which R is hydrogen or (C1-C7) alkyl; and
R4 is hydrogen.

### Claim 6 (depends on 1)

The amide compound, the pharmaceutically acceptable salt thereof, or the solvate thereof of claim 1, wherein the amide compound is represented by the following Chemical Formula 2:
wherein
R1 and R2 are independently of each other (C1-C30) alkyl; and
R11 is selected from the following structures, in which R21 and R22 are independently of each other hydrogen or (C1-C7) alkyl:

### Claim 7 (depends on 1)

The amide compound, the pharmaceutically acceptable salt thereof, or the solvate thereof of claim 1, wherein R1 and R2 are independently of each other (C4-C30) alkyl.

### Claim 8

An amide compound represented by the following Chemical Formula 1, a pharmaceutically acceptable salt thereof, or a solvate thereof:
wherein
R1 and R2 are independently of each other (C1-C30) alkyl;
one selected from R3 and R4 is (C1-C30) alkyl, and the other one is hydrogen or (C1-C30) alkyl;
R5 is hydrogen or (C1-C30)alkyl; and
the alkyl of R3 and R4 may be further substituted by one or more substituents selected from hydroxy; (C1-C30) alkoxy; (C1-C30) alkylthio; and amino, guanidino, —(C═O)NH2, —(C═O)OR, (C3-C30) heteroaryl, and salts thereof, in which R is hydrogen or (C1-C30) alkyl, and the heteroaryl contains N.
